• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[良性前列腺增生的恰当治疗;通过专家意见的系统分析完善治疗指征]

[Appropriate treatment of benign prostatic hyperplasia; refining the indications for treatment by systematic analysis of expert opinion].

作者信息

Stoevelaar H J, McDonnell J, van de Beek C, Casparie A F

机构信息

Erasmus Universiteit, Instituut Beleid en Management Gezondheidszorg, Rotterdam.

出版信息

Ned Tijdschr Geneeskd. 1999 Nov 27;143(48):2425-9.

PMID:10608977
Abstract

OBJECTIVE

To assess systematically the opinion of urology experts regarding the appropriateness of indications for treatment of benign prostatic hyperplasia (BPH) and to evaluate the potential use of these expert opinions for the refinement of treatment guidelines.

DESIGN

Modified Delphi procedure.

METHODS

A panel of 12 Dutch urologists judged the appropriateness of three common treatments (surgery, alpha-adrenergic antagonists, finasteride) for 1152 hypothetical cases of BPH. These cases consisted of all combinations of 9 diagnostic characteristics considered relevant to treatment choice. The study population was restricted to patients for whom current (evidence-based) guidelines do not provide clear indications on the most appropriate treatment. The panel members individually rated the appropriateness of the three active treatments using a 1 to 9 scale, each in comparison with 'watchful waiting'. By combining the results on agreement and appropriateness, aggregate panel judgements were calculated for each indication (appropriate, inappropriate, uncertain). The relationship between diagnostic characteristics and panel opinions was studied using logistic regression methods.

RESULTS

For patients without previous treatment for BPH, surgery was considered appropriate in 44% of cases. For alpha-blocking drugs and finasteride, these values were 70% and 3% respectively. Logistic regression analysis revealed a strong and consistent relationship between the several diagnostic characteristics and the panel judgement 'appropriate indication'.

CONCLUSION

Systematic analysis of clinical expertise can offer a meaningful contribution to the refinement of indications for BPH treatments.

摘要

目的

系统评估泌尿外科专家对良性前列腺增生(BPH)治疗指征适宜性的看法,并评估这些专家意见在完善治疗指南方面的潜在用途。

设计

改良德尔菲法。

方法

一个由12名荷兰泌尿外科医生组成的小组对1152例假设的BPH病例的三种常见治疗方法(手术、α-肾上腺素能拮抗剂、非那雄胺)的适宜性进行了判断。这些病例由9种与治疗选择相关的诊断特征的所有组合构成。研究人群仅限于当前(循证)指南未就最合适治疗提供明确指征的患者。小组成员使用1至9分的量表分别对三种积极治疗方法与“观察等待”相比的适宜性进行评分。通过综合一致性和适宜性结果,计算每个指征的小组总体判断(适宜、不适宜、不确定)。使用逻辑回归方法研究诊断特征与小组意见之间的关系。

结果

对于未曾接受过BPH治疗的患者,44%的病例中手术被认为是适宜的。对于α-阻滞剂和非那雄胺,这些比例分别为70%和3%。逻辑回归分析显示,几种诊断特征与小组判断“适宜指征”之间存在强烈且一致的关系。

结论

对临床专业知识的系统分析可为完善BPH治疗指征做出有意义的贡献。

相似文献

1
[Appropriate treatment of benign prostatic hyperplasia; refining the indications for treatment by systematic analysis of expert opinion].[良性前列腺增生的恰当治疗;通过专家意见的系统分析完善治疗指征]
Ned Tijdschr Geneeskd. 1999 Nov 27;143(48):2425-9.
2
Lower urinary tract symptoms suggestive of benign prostatic obstruction: how can clinical expertise contribute to rational management?提示良性前列腺梗阻的下尿路症状:临床专业知识如何有助于合理管理?
Eur Urol. 2001;39 Suppl 3:13-9. doi: 10.1159/000052562.
3
Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.经济建模,以评估非那雄胺、特拉唑嗪及经尿道前列腺切除术治疗中度至重度良性前列腺增生症状男性患者的治疗成本。
Urology. 1995 Oct;46(4):477-83. doi: 10.1016/S0090-4295(99)80258-1.
4
[Factors determining treatment strategies for patients with benign prostatic hyperplasia. The DUO study].[良性前列腺增生患者治疗策略的决定因素。DUO研究]
Presse Med. 2007 May;36(5 Pt 1):755-63. doi: 10.1016/j.lpm.2006.12.027. Epub 2007 Feb 27.
5
[Treatment of benign prostate hyperplasia].[良性前列腺增生的治疗]
Orv Hetil. 2010 Mar 21;151(12):506-8. doi: 10.1556/OH.2010.28809.
6
Evaluation and medical management of benign prostatic hyperplasia.良性前列腺增生的评估与药物治疗
Mayo Clin Proc. 2005 Oct;80(10):1356-62. doi: 10.4065/80.10.1356.
7
Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.非那雄胺、特拉唑嗪治疗或密切观察等待的良性前列腺增生男性患者中游离前列腺特异性抗原水平百分比的比较。
Urology. 1997 Dec;50(6):901-5. doi: 10.1016/S0090-4295(97)00453-6.
8
The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.5-α还原酶抑制剂对良性前列腺增生前列腺切除术数量的影响。
Adv Ther. 1995 Nov-Dec;12(6):361-6.
9
Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.良性前列腺增生:诊断与治疗。医疗保健政策与研究机构。
Clin Pract Guidel Quick Ref Guide Clin. 1994 Feb(8):1-17.
10
Benign prostatic hyperplasia (BPH).良性前列腺增生(BPH)。
Harv Mens Health Watch. 2006 Aug;11(1):3.

引用本文的文献

1
Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.良性前列腺增生治疗方案的变更:临床与经济考量
Pharmacoeconomics. 2001;19(2):131-53. doi: 10.2165/00019053-200119020-00003.